Corbus Pharmaceuticals Holdings, Inc. (CRBP)
9.65
-0.61
(-5.95%)
USD |
NASDAQ |
Dec 11, 16:00
9.96
+0.31
(+3.21%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings EPS Diluted (Quarterly): -1.897 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.34M |
| Total Expenses (Quarterly) | 23.34M |
| Enterprise Value | 77.88M |
| Earnings Yield | -57.13% |
| Normalized Earnings Yield | -57.13 |